Source: Research Update on PARP Inhibition: Emerging Data in Breast, Ovarian, and Other Cancers
William J. Gradishar, MD, FACP, reviews the mechanism of PARP inhibition and its rationale as a therapeutic pathway and describes recent data using novel PARP inhibitors.
Download slides on recent data in PARP inhibitors in breast, ovarian, and other solid tumors.
*You must be logged into the clinicaloptions.com site to view or save the slides. (free)
Users are encouraged to use these slides in their own presentations, but we ask that content and attribution not be changed. Users are asked to honor this intent. These slides may not be published or posted online without permission from Clinical Care Options.